Nutraceuticals products that bridge the gap between food and medicine are rapidly gaining global popularity. However, their growth is complicated by major differences in how countries regulate them. A comparison of the United States, India, and the European Union highlights how these varying frameworks impact both product safety and international market access.
In the United States, regulations emphasize manufacturer responsibility and post-market surveillance, allowing faster product entry but raising safety concerns. India follows a simpler registration process, encouraging industry growth but with relatively less stringent evaluation. In contrast, the European Union requires rigorous pre-market approval and scientific validation, ensuring high safety standards but slowing innovation.
These regulatory differences create barriers for global trade and lead to inconsistent safety standards. Harmonizing international guidelines could improve consumer protection, simplify market entry, and support the sustainable growth of the nutraceutical industry. As demand rises, aligning regulations will be key to building trust and ensuring product safety worldwide.
Source : https://www.sciencedirect.com/science/article/abs/pii/S2213434425000027
